Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01599585 · ClinicalTrials.gov registry record · NA

A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression

A NA study, sponsored by National Center for Telehealth and Technology.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT01599585: Completed NA study, sponsored by National Center for Telehealth and Technology.

NCT01599585 is a NA study that has completed, run by National Center for Telehealth and Technology. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01599585, a NA study, has completed, sponsored by National Center for Telehealth and Technology.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

This study will evaluate the effectiveness of a web-based behavioral activation(BA) treatment for depression by comparing it to in-person BA treatment in Soldiers and Veterans with Major and Minor Depressive Disorder. We will test the hypothesis that 8 sessions of in-home BA delivered via a webcam will be as safe and effective in reducing symptoms of hopelessness and depression as in-person BA treatment for depression.

Primary Outcome

The BHS is a 20-item scale for measuring negative attitudes about the future. Each item is scored with a true/false response. Total scores range from 0-20 with higher scores indicating a greater degree of hopelessness.

Interventions

  • BEHAVIORAL Behavioral Activation

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2012-05
Est. Completion 2016-10
Phase NA

What the finished NCT01599585 record still lists

NCT01599585 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral Activation is the first listed.

NCT01599585 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01599585 about?

NCT01599585 is a clinical study titled "A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression". This study will evaluate the effectiveness of a web-based behavioral activation(BA) treatment for depression by comparing it to in-person BA treatment in Soldiers and Veterans with Major and Minor Depressive Disorder. We will test the hypothesis that 8 sessions of in-home BA delivered via a webcam w...

What is the current status of trial NCT01599585?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2012-05. Estimated completion is 2016-10.

What interventions are being tested in trial NCT01599585?

The interventions under investigation include: Behavioral Activation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01599585?

This trial is sponsored by National Center for Telehealth and Technology, which has 5 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01599585's enrollment target sits among peer trials

121 762nd of 2000 higher than 1,239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03476681 · 121 participants · Phase 1

    Study of NEO-201 in Solid Tumors Expansion Cohorts

  • NCT04655118 · 121 participants · Phase 2

    Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis

  • NCT04676802 · 121 participants · Phase 2

    Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

  • NCT05169515 · 121 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01599585, the US trial registry maintained by the National Library of Medicine. NCT01599585 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.